| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | 3 | — | — |
| Sell | — | 1 | — | 1 | 1 | — | — | — | — | — | — | — |
| total | individual payouts | |
|---|---|---|
| 2022 | ‡‡‡ |
|
| 2021 | ‡‡‡ |
|
| 2020 | ‡‡‡ |
|
| 2019 | ‡‡‡ |
|
| 2017 | ‡‡‡ |
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 11.46 | 3.61 | 3.47 | 4.78 |
| Receivables | 3.03 | 0.51 | 2.79 | 3.38 |
| Inventory | 5.79 | 6.17 | 4.97 | 4.31 |
| Other | — | — | — | — |
| 21.23 | 10.47 | 11.42 | 13.20 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 1.11 | 0.61 | 0.62 | 0.76 |
| ST’ Debt | — | — | — | — |
| Other | 20.71 | 10.16 | 0.06 | 0.10 |
| 23.53 | 13.20 | 1.82 | 1.64 |
| 10y | 5y | 3y | |
| Sales | — | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | — | ‡‡‡ | ‡‡‡ |
| Earnings | — | ‡‡‡ | ‡‡‡ |
| Book Value | — | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 1.11 | 2.05 | — | — |
—
|
| ’25 | 0.77 | 1.01 | 1.49 | 1.40 |
4.67
|
| ’24 | 1.48 | 1.57 | 0.59 | 0.87 |
4.51
|
| ’23 | 0.71 | 1.20 | 3.63 | 0.59 |
6.13
|
| ’22 | 1.60 | 1.17 | 1.70 | 3.58 |
8.05
|
| ’21 | 1.54 | 1.93 | 1.81 | 2.45 |
7.73
|
| ’20 | 0.69 | 0.83 | 1.01 | 1.41 |
3.94
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (1.25) | (2.43) | — | — |
—
|
| ’25 | (3.07) | (1.94) | (2.61) | (2.66) |
(10.29)
|
| ’24 | (3.72) | (3.52) | 0.33 | (1.21) |
(8.12)
|
| ’23 | (3.07) | 2.29 | (12.14) | (3.78) |
(16.70)
|
| ’22 | (4.85) | (1.36) | (4.83) | (3.57) |
(14.60)
|
| ’21 | (4.44) | (5.81) | (3.47) | (4.49) |
(18.22)
|
| ’20 | (2.24) | (1.66) | (3.80) | (4.49) |
(12.19)
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (1.30) | (2.48) | — | — |
—
|
| ’25 | (3.11) | (2.05) | (2.71) | (2.80) |
(10.68)
|
| ’24 | (3.80) | (3.55) | 0.30 | (1.24) |
(8.29)
|
| ’23 | (3.21) | 2.19 | (12.36) | (3.94) |
(17.33)
|
| ’22 | (5.00) | (1.48) | (4.89) | (4.36) |
(15.73)
|
| ’21 | (4.66) | (6.06) | (4.51) | (4.92) |
(20.15)
|
| ’20 | (2.29) | (1.76) | (3.95) | (5.11) |
(13.11)
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (0.09) | (0.04) | — | — |
—
|
| ’25 | 0.00 | (0.07) | (0.06) | (0.08) |
(0.22)
|
| ’24 | 0.00 | (0.02) | 0.04 | (0.17) |
(0.16)
|
| ’23 | (0.10) | (0.12) | (0.07) | (0.44) |
(0.72)
|
| ’22 | (0.13) | (0.12) | (0.09) | (0.09) |
(0.43)
|
| ’21 | (0.14) | (0.20) | (0.15) | (0.13) |
(0.62)
|
| ’20 | (0.08) | (0.09) | (0.11) | (0.10) |
(0.37)
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | ‡‡‡ | ‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 1.07 | 0.95 | 1.21 | 1.20 | — | — | — |
Low Price
|
| — | — | ‡‡‡ | ‡‡‡ | ‡‡‡‡ | ‡‡‡ | 4.56 | 3.40 | 7.01 | 3.00 | — | — | — |
High Price
|
| — | ‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 69 | 52 | 19 | 25 | — | — | — |
Employees
|
| — | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.12 | 0.12 | 0.24 | 0.19 | — | — | — |
Revenue/Emp
|
| — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 8.05 | 6.13 | 4.51 | 4.67 | — | — | — |
Revenue
|
| — | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 46.39% | 47.38% | 54.69% | 57.77% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (17.62) | (30.22) | (5.87) | (10.33) | — | — | — |
EBT
|
| ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (218.87%) | (492.74%) | (130.35%) | (221.21%) | — | — | — |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (17.62) | (30.22) | (5.87) | (10.33) | — | — | — |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.76 | 0.82 | 0.83 | 0.59 | — | — | — |
Depreciation
|
| ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.20 | 0.14 | 0.10 | 0.09 | — | — | — |
Revenue/Sh
|
| — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.43) | (0.72) | (0.16) | (0.22) | — | — | — |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.35) | (0.39) | (0.18) | (0.20) | — | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.03) | (0.01) | 0.00 | (0.01) | — | — | — |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.38) | (0.41) | (0.18) | (0.21) | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.66 | 0.07 | 0.01 | 0.23 | — | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 41.17 | 42.32 | 45.62 | 50.39 | — | — | — |
Shares
|
| — | — | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
PE Ratio
|
| — | — | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 8.75 | 18.77 | 21.46 | 25.67 | — | — | — |
PS Ratio
|
| — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.60 | 36.40 | 386.87 | 10.44 | — | — | — |
PB Ratio
|
| — | — | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 6.39 | 16.94 | 20.71 | 24.97 | — | — | — |
EV/Sales
|
| — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (3.27) | (6.00) | (11.25) | (10.93) | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (14.60) | (16.70) | (8.12) | (10.29) | — | — | — |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (1.13) | (0.62) | (0.17) | (0.39) | — | — | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (15.73) | (17.33) | (8.29) | (10.68) | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 23.70 | (2.30) | (2.73) | 9.60 | — | — | — |
Working Cap'
|
| — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.30 | — | — | — | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (18.98) | (11.45) | (3.61) | (3.47) | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 27.06 | 3.16 | 0.25 | 11.49 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (47.10%) | (103.64%) | (32.52%) | (73.60%) | — | — | — |
ROA
|
| ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (137.20%) | 0.00% | 0.00% | (105.06%) | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (51.57%) | (202.61%) | (415.65%) | (191.45%) | — | — | — |
ROE
|
Wrap Technologies (WRAP), pioneer of the BolaWrap remote restraint device, rode a wave of demand for non-lethal policing tools post-2020 unrest, surging revenues 1,055% from $0.7 million in 2019 to $8 million in 2022. Yet, a brutal reversal followed: sales plunged 44% to $4.5 million by 2024 amid municipal budget squeezes, 72% workforce cuts, and rivals like Axon dominating the space. Gross margins ballooned to 54.7% through ruthless cost controls, narrowing losses 81% to -$5.9 million, but persistent cash burn, evaporating equity (down 92% to a mere $250,000), and a book value wipeout signal a company teetering on the edge of dilution or distress.
Insider actions scream caution: zero buys in a year, but $2.7 million in sales by top executives and 10% owners, timed amid multi-year stock lows ($0.95 in 2023). The shares, once soaring to $14, now languish with a precarious 387x PB ratio and negative free cash flow, decoupling from improving per-employee productivity despite macro tailwinds like election-year budgets.
Analysts eye 40% upside to stabilization via BolaWrap upgrades and margin leverage toward breakeven by 2026-27—but in a sector growing at single digits, with recession risks and no debt cushion, WRAP remains a high-octane gamble for contrarians betting against further erosion.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.